SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor-Naive Patients With Myelofibrosis - Mesa, R A; Kiladjian, J J; Catalano, J V (J Clin Oncol, 2017)
et al.